Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Comprehensive Viral Research Panel

Twist Bioscience has released the Twist Comprehensive Viral Research Panel, a next-generation sequencing-based, research-use only assay that includes 3,153 viral genomes and enables identification of new and divergent viral species. The product uses over a million unique probes targeting sequences compiled from RefSeq, FluDB, and VIPRdb, representing all viral families containing at least one virus known to infect humans.

The panel covers all viral types: single- and double-stranded DNA and RNA genomes. It detects viral co-infections and can be used for metagenomic surveillance applications in stool samples.

The panel will be bundled with analysis software from One Codex.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.